Literature DB >> 12608711

Quantitative analysis of MAP2 immunoreactivity in human neocortex of three patients surviving after brain ischemia.

Victor A Akulinin1, Annica Dahlstrom.   

Abstract

Transient global ischemia caused by cardiac arrest results in lesions that involve all brain structures. The aim of this study was to investigate the distribution of MAP2 immunoreactivity in neurons in the brain of patients surviving for various times after an ischemic incident, using confocal laser scanning microscopy. We performed a quantitative analysis of the distribution and density of MAP2-positive structures in human neocortical areas after survival times of 1 week, 3 months, and 1 year after the cardiac arrest. Three important observations were made in the present study: (i) in all human brain areas investigated (motor, temporal, frontal, and visual cortex) a decrease of MAP2 immunoreactivity was found; (ii) in all studied areas the most significant decrease in MAP2 was found in layers II-III, compared with layers V-VII; (iii) the decrease of MAP2 immunoreactivity in layers II-III was related to the duration of the postischemic period. The maximal decrease, by 66.3% (P < .05), in MAP2-positive pyramidal neurons, was observed in layers II-III in the motor cortex after 1 year of survival after cardiac arrest.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608711     DOI: 10.1023/a:1022401922669

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  Hypoxic-ischemic injury acutely disrupts microtubule-associated protein 2 immunostaining in neonatal rat brain.

Authors:  C Malinak; F S Silverstein
Journal:  Biol Neonate       Date:  1996

2.  Changes in the concentrations of cerebral proteins following occlusion of the middle cerebral artery in rats.

Authors:  T Inuzuka; A Tamura; S Sato; T Kirino; K Yanagisawa; I Toyoshima; T Miyatake
Journal:  Stroke       Date:  1990-06       Impact factor: 7.914

3.  Selective dendrite damage in hippocampal CA1 stratum radiatum with unchanged axon ultrastructure and glutamate uptake after transient cerebral ischaemia in the rat.

Authors:  F F Johansen; M B Jørgensen; D K Ekström von Lubitz; N H Diemer
Journal:  Brain Res       Date:  1984-01-23       Impact factor: 3.252

4.  Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia.

Authors:  C E Marx; L F Jarskog; J M Lauder; J A Lieberman; J H Gilmore
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

5.  Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study.

Authors:  G V Johnson; J M Litersky; R S Jope
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

6.  Acute anoxia-induced alterations in MAP2 immunoreactivity and neuronal morphology in rat hippocampus.

Authors:  S Kwei; C Jiang; G G Haddad
Journal:  Brain Res       Date:  1993-08-27       Impact factor: 3.252

7.  Early immunohistochemical changes of microtubule based motor proteins in gerbil hippocampus after transient ischemia.

Authors:  M Aoki; K Abe; T Yoshida; A Hattori; K Kogure; Y Itoyama
Journal:  Brain Res       Date:  1995-01-16       Impact factor: 3.252

8.  Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage.

Authors:  R T Bartus; K L Baker; A D Heiser; S D Sawyer; R L Dean; P J Elliott; J A Straub
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

9.  Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study.

Authors:  A Sotrel; R S Williams; W E Kaufmann; R H Myers
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

Review 10.  The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration.

Authors:  G V Johnson; R S Jope
Journal:  J Neurosci Res       Date:  1992-12       Impact factor: 4.164

View more
  4 in total

1.  MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia.

Authors:  Rebecca DeGiosio; Ryan M Kelly; Adam M DeDionisio; Jason T Newman; Kenneth N Fish; Allan R Sampson; David A Lewis; Robert A Sweet
Journal:  NPJ Schizophr       Date:  2019-08-28

Review 2.  Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review).

Authors:  Johanna Andrea Gutiérrez-Vargas; John Fredy Castro-Álvarez; Jose Fernando Zapata-Berruecos; Komal Abdul-Rahim; Anibal Arteaga-Noriega
Journal:  Biomed Rep       Date:  2022-02-18

3.  More than a marker: potential pathogenic functions of MAP2.

Authors:  Rebecca A DeGiosio; Melanie J Grubisha; Matthew L MacDonald; Brandon C McKinney; Carlos J Camacho; Robert A Sweet
Journal:  Front Mol Neurosci       Date:  2022-09-16       Impact factor: 6.261

4.  Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex.

Authors:  Sirui Jiang; Priya Nandy; Wenzhang Wang; Xiaopin Ma; Jeffrey Hsia; Chunyu Wang; Zhenlian Wang; Mengyue Niu; Sandra L Siedlak; Sandy Torres; Hisashi Fujioka; Ying Xu; Hyoung-Gon Lee; George Perry; Jun Liu; Xiongwei Zhu
Journal:  Mol Neurodegener       Date:  2018-02-01       Impact factor: 14.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.